INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›Kerala High Court Rules Centre Can Use Section 100 of Patents Act for Affordable Life-Saving Drugs
health

Kerala High Court Rules Centre Can Use Section 100 of Patents Act for Affordable Life-Saving Drugs

By Info60 India Desk•Summary of reporting by Suspense Crime•1d ago•0 views•
Kerala High Court Rules Centre Can Use Section 100 of Patents Act for Affordable Life-Saving Drugs
In a landmark judicial pronouncement addressing the staggering cost of critical healthcare, the Kerala High Court has ruled that the Central Government holds the…
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Childhood Obesity: How Can It Be Avoided?

Childhood Obesity: How Can It Be Avoided?

Newswise

WHO Reports Latest Global Trends in Cholera, Meningitis and Plague

WHO Reports Latest Global Trends in Cholera, Meningitis and Plague

The Indian Practitioner

Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses

Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses

NDTV

India has PET-CT machines-So why are cancer patients still waiting for reports?

India has PET-CT machines-So why are cancer patients still waiting for reports?

theweek.in

Decaf helps the memory, and caffeine eases anxiety: Coffee study

Decaf helps the memory, and caffeine eases anxiety: Coffee study

ThePrint

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!